Wallace DJ, Ginzler EM, Merrill JT, et al. Sustained safety and efficacy over 10 years with belimumab (BEL) plus standard systemic lupus erythematosus (SLE) therapy (SOC) in patients with SLE. EULAR 2017, #OP0232.
Risico op longembolie en diepveneuze trombose verhoogd bij reumatoïde artritis
sep 2020 | Benigne hematologie, RA